NOTCH2 and B-cell chronic lymphocytic leukemia: In terms of CLL biology, constitutive active NOTCH2 might dominantly suppress apoptotic NOTCH3 signaling, thereby enabling the (self-) antigen-driven progredient expansion of the malignant clone.